By
AstraZeneca
Published: March 21, 2014, 5:57 p.m.·
Tags:
Advocacy,
Pharma industry,
Research and development
AstraZeneca's response to open letter expressing concern for its departure from tuberculosis and urging the company to ensure continued investment in the field.
Read More →
By
AstraZeneca
Published: July 3, 2012, 4:33 p.m.·
Tags:
None
AstraZeneca and Cellworks today announced a collaboration supported by the Wellcome Trust to speed the design of novel combination therapies for the treatment of drug-sensitive and resistant tuberculosis. This collaboration will also pave the way for the creation of platforms and approaches to handle Multi Drug Resistant Tuberculosis (MDR-TB), a condition that is reaching epidemic proportions in many developing parts of the world.
Read More →